Clinical Trial Update: BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BDP/FF to formoterol fumarate in severe COPD assessing lung function and exacerbation rate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BDP/FF
• FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED